PharVision Advisers’s Planet Labs PL Stock Holding History

PharVision Advisers’s Portfolio PL Stock Details PL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,048	Closed	-$533K	–	509
2025 Q4	$533K	Sell	27,048 -1,320	-5%	-$18.9K	0.27%	27
2025 Q3	$368K	Buy	+28,368	New	+$219K	0.21%	113

Other funds holding PL

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's PL Position: Q1 2026 in Review

PharVision Advisers sold out of Planet Labs (PL) in Q1 2026, closing a stake of 27,048 shares — an estimated $533K sold.

PharVision Advisers first reported a position in PL in Q3 2025 and held it in 2 quarters. The position peaked at $533K in Q4 2025. 419 funds tracked by Wall St. Rank hold PL as of Q1 2026.

PharVision Advisers reported no remaining Planet Labs position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 27,048 Planet Labs shares in Q1 2026, an estimated $533K.
PharVision Advisers first reported a position in Planet Labs in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Planet Labs position peaked at $533K in Q4 2025.
419 funds tracked by Wall St. Rank held Planet Labs as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.